Trials by Active Ingredient
Tapentadol
| Trial identifier (Sponsor): | KF5503-72 |
| Trade name: | Palexia®, Nucynta®, Yantil® |
| INN / Sponsor substance code: | Tapentadol |
| Trial title: | Open-label evaluation of the population pharmacokinetic profile, safety, tolerability, and efficacy of tapentadol oral solution for the treatment of post-surgical pain in children aged from birth to less than 2 years |
| Brief title: | Use of tapentadol oral solution for pain after surgery in children from newborn to less than 2 years old |
| Trial indication: | Moderate to severe acute post-operative pain |
| Trial status: | Ongoing |
| Results posted: | No |
| PubMed unique identifier [PMID]: | -- |
| First subject enrolled: | -- |
| Last subject completed: | -- |
| UTN (WHO): | U1111-1153-1662 |
| ClinicalTrials.gov identifier: | NCT02221674 |
| Eudra CT identifier: | 2014-000623-24 |
| Available for data sharing: | No |
| Trial phase: | 2 |
